Mesenchymal stem cell-based TRAIL delivery inhibits the metastatic state of clinical therapy-resistant progressive neuroblastoma

Affiliations

• ¹ Department of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
• ² Stephenson Cancer Center, Oklahoma City, OK, USA.
• ³ Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
• ⁴ Department of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. naravind@ouhsc.edu.
• ⁵ Stephenson Cancer Center, Oklahoma City, OK, USA. naravind@ouhsc.edu.
• ⁶ Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. naravind@ouhsc.edu.
• ⁷ Radiation Biology Laboratory, University of Oklahoma Health Sciences Center, BSEB 302F, 941 Stanton L. Young Boulevard, Oklahoma City, OK, 73104, USA. naravind@ouhsc.edu.